Cargando…
Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA
Dementia affects all domains of cognition. The relentless progression of the disease after diagnosis is associated with a 98% incidence of neuropsychiatric symptoms (NPS) at some point in the disease, including depression, psychosis, agitation, aggression, apathy, sleep disturbances, and disinhibiti...
Autores principales: | Phan, Stephanie V., Osae, Sharmon, Morgan, John C., Inyang, Mfon, Fagan, Susan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544588/ https://www.ncbi.nlm.nih.gov/pubmed/31098864 http://dx.doi.org/10.1007/s40268-019-0272-1 |
Ejemplares similares
-
Maintenance Pharmacotherapies for Neuropsychiatric Disorders
por: Richards, Stephanie
Publicado: (2013) -
Atypical antipsychotics to treat the neuropsychiatric symptoms of dementia
por: Lee, Philip E, et al.
Publicado: (2006) -
Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015) -
Neuropsychiatric symptoms and severity of dementia
por: Caldas, Gustavo Henrique de Oliveira, et al.
Publicado: (2013) -
Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms
por: Vuic, Barbara, et al.
Publicado: (2023)